India, Feb. 5 -- Chennai-based startup MrMed, a direct-to-patient platform for critical care and super-specialty medicines, has announced a new phase of accelerated growth, driven by expanded physical infrastructure, enhanced cold-chain capabilities, and a widening national footprint.

Recognising the importance of timely access to life-saving and temperature-sensitive medicines, MrMed has expanded its physical presence with the establishment of on-ground operations in Guwahati, alongside its existing presence in Chennai, Delhi and Bengaluru. This expansion is aimed at strengthening last-mile access and improving fulfilment timelines across regions.

As part of its infrastructure expansion, the company has also launched an offline cold-ch...